epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Aqneursa
    levacetylleucine
  • remove Depen
    penicillamine
  • remove Lamzede (velmanase alfa-tycv)
    velmanase alfa
  • remove Skysona
    elivaldogene autotemcel

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Depen (penicillamine) + Skysona (elivaldogene autotemcel)

Avoid/Use Alternative


penicillamine + elivaldogene autotemcel

consider alternative or monitor CBC, bleeding s/sx: combo may incr. risk of myelosuppression (additive effects)

Additional Considerations

Smiley face Smiley face levacetylleucine in Aqneursa

avoid combo with N-acetyl-DL-leucine or N-acetyl-D-leucine; competition for transporter uptake may decr. levacetylleucine efficacy

Smiley face Smiley face penicillamine in Depen

separate administration from other oral drugs by >1h; penicillamine may be inactivated by and decr. absorption of concomitant oral drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information